It suggested that when M-TLSs abundance was comparable, the predominant cells mediating antitumor immunity in M-TLSs within the tumor region were proliferating CD20+ B cells, CD21+ cells, and CD4+ Th cells, rather than proliferating CD8+ cytotoxic T lymphocytes. This evidence concerns the gene CR2 and neoplasm.